Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

Clinical trial NCT05334368 · RECRUITING

Trial details

NCT number: NCT05334368
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypereosinophilic Syndrome

Start date: 2022-09-06
Primary completion: 2028-12-19
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.